Dr. Chu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
49 Nesconset Hwy
Port Jefferson Station, NY 11776Phone+1 631-751-3000Fax+1 631-675-2001
Education & Training
- Stony Brook Medicine/University HospitalFellowship, Hematology and Medical Oncology, 2006 - 2009
- Stony Brook Medicine/University HospitalResidency, Internal Medicine, 2003 - 2006
- St. George's University School of MedicineClass of 2003
Certifications & Licensure
- NJ State Medical License 2019 - 2025
- NY State Medical License 2008 - 2025
- PA State Medical License 2020 - 2024
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2011-2013
Clinical Trials
- Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC) Start of enrollment: 2015 Jun 26
- Trilaciclib (G1T28) in Patients With Previously Treated Extensive Stage SCLC Receiving Topotecan Chemotherapy Start of enrollment: 2015 Oct 05
- TR(ACE) Assay Clinical Specimen Study Start of enrollment: 2016 Sep 01
Publications & Presentations
PubMed
- 297 citationsRisk of gastrointestinal perforation in patients with cancer treated with bevacizumab: a meta-analysisSanjaykumar Hapani, David Chu, Shenhong Wu
The Lancet. Oncology. 2009-06-01 - 140 citationsRisk of hand-foot skin reaction with sorafenib: a systematic review and meta-analysis.David Chu, Mario E. Lacouture, Triantafillos Fillos, Shenhong Wu
Acta Oncologica. 2008-01-01 - 4 citationsDisease and Clinical Characteristics of Patients With a Clinical Diagnosis of Essential Thrombocythemia Enrolled in the MOST Study.Abdulraheem Yacoub, Roger M. Lyons, Srdan Verstovsek, Ryan Shao, David Tin Chu
Clinical Lymphoma, Myeloma & Leukemia. 2021-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: